Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on February 25, 2019. The filing serves as a Regulation FD disclosure regarding a corporate governance event rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document contains no financial statements or performance data.
Material Changes
The primary material event reported is the adjournment of the Company's special meeting of stockholders. The meeting was rescheduled to Thursday, February 28, 2019, at 8:30 a.m. Pacific Standard Time. The location remains 201 Mission Street, Suite 2375, San Francisco, CA.
Guidance, Outlook, and Risks
The filing does not contain management guidance, outlook, or specific risk factors beyond the standard disclaimer that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act. The Company is identified as an emerging growth company that has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Investor Verification Checklist
- Verify the new date and time for the special meeting of stockholders (February 28, 2019, 8:30 a.m. PST).
- Confirm the meeting location at 201 Mission Street, Suite 2375, San Francisco, CA.
- Review the attached press release (Exhibit 99.1) for details on the agenda of the adjourned meeting.
- Note that this filing does not update the Company's financial position or operating results.